Letter

Self monitoring in diabetes

Useful in which patients?

BMJ 2007; 335 doi: 10.1136/bmj.39297.457014.1F (Published 9 August 2007)
Cite this as: BMJ 2007;335:271.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Andrew Moore, editor, Bandolier,
  2. Sheena Derry, senior research associate,
  3. Grace McGeogh, medical student
  1. Pain Research, Nuffield Department of Anaesthetics, University of Oxford, The Churchill, Oxford OX3 7LJ
  1. andrew.moore{at}pru.ox.ac.uk

    The conclusion of the randomised trial reported by Farmer et al1 is in line with a recent systematic review of randomised trials (1000 patients, three trials) and observational studies (60 000 patients, 13 studies),2 which shows that only when the average starting HbA1c is above 8% do studies consistently show benefit of self monitoring.

    The inference that …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular